---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-032694"
form_type: "8-K"
ticker: "BBLG"
cik: "0001419554"
company_name: "Bone Biologics Corp"
filed_at: "2026-07-09T20:30:35+00:00"
generated_at: "2026-07-09T20:31:07.323167+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Bone Biologics prices $3.0M private placement with up to $6.0M in warrant proceeds

## Summary
- Gross proceeds of ~$3.0M from sale of 2,112,677 pre-funded warrants and Series F/G warrants at $1.419 per unit.
- Potential additional ~$6.0M if Series F (5-year) and Series G (18-month) warrants fully exercised at $1.42/share.
- Net proceeds ~$2.7M after fees; intended for clinical trials, patent portfolio, and working capital.
- H.C. Wainwright acted as exclusive placement agent; received 7.0% cash fee and 126,761 placement agent warrants.
- Company to seek stockholder approval for warrant issuance; resale registration statement to be filed within 15 days.

## SEC filing metadata
- accession: 0001493152-26-032694
- form_type: 8-K
- ticker: BBLG
- cik: 0001419554
- company_name: Bone Biologics Corp
- filed_at: 2026-07-09T20:30:35+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419554/000149315226032694/0001493152-26-032694-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419554/000149315226032694/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-032694
- JSON: https://secwatch.observer/filing/0001493152-26-032694.json
- Plain text: https://secwatch.observer/filing/0001493152-26-032694.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.